% IMPORTANT: The following is UTF-8 encoded.  This means that in the presence
% of non-ASCII characters, it will not work with BibTeX 0.99 or older.
% Instead, you should use an up-to-date BibTeX implementation like “bibtex8” or
% “biber”.

@ARTICLE{Jaramillo:290602,
      author       = {S. Jaramillo and J. Krisam and L. Le Cornet$^*$ and M.
                      Kratzmann$^*$ and L. Baumann and O. Eissymont and M.
                      Crysandt and M. Görner and S. Kayser$^*$ and S. Krause and
                      C. Schliemann and T. Gaska and M. Kaufmann and J. Chemnitz
                      and M. Schaich and A. Hoellein and U. Platzbecker and M.
                      Kieser and C. Müller-Tidow and R. Schlenk$^*$},
      title        = {{R}andomized phase {III} {G}n{G} study on two schedules of
                      gemtuzumab ozogamicin as adjunct to intensive induction
                      therapy and double-blinded intensive postremission therapy
                      with or without glasdegib in patients with newly diagnosed
                      acute myeloid leukemia.},
      journal      = {Haematologica},
      volume       = {109},
      number       = {6},
      issn         = {0390-6078},
      address      = {Pavia},
      publisher    = {Ferrata Storti Foundation},
      reportid     = {DKFZ-2024-01199},
      pages        = {1973-1976},
      year         = {2024},
      note         = {#LA:W010#},
      subtyp        = {Letter},
      keywords     = {Humans / Gemtuzumab: therapeutic use / Gemtuzumab:
                      administration $\&$ dosage / Leukemia, Myeloid, Acute: drug
                      therapy / Leukemia, Myeloid, Acute: diagnosis /
                      Antineoplastic Combined Chemotherapy Protocols: therapeutic
                      use / Antineoplastic Combined Chemotherapy Protocols:
                      adverse effects / Aminoglycosides: therapeutic use /
                      Aminoglycosides: administration $\&$ dosage / Double-Blind
                      Method / Male / Female / Middle Aged / Remission Induction /
                      Aged / Induction Chemotherapy / Adult / Treatment Outcome /
                      Benzimidazoles / Phenylurea Compounds / Gemtuzumab (NLM
                      Chemicals) / Aminoglycosides (NLM Chemicals) / glasdegib
                      (NLM Chemicals) / Benzimidazoles (NLM Chemicals) /
                      Phenylurea Compounds (NLM Chemicals)},
      cin          = {W010},
      ddc          = {610},
      cid          = {I:(DE-He78)W010-20160331},
      pnm          = {311 - Zellbiologie und Tumorbiologie (POF4-311)},
      pid          = {G:(DE-HGF)POF4-311},
      typ          = {PUB:(DE-HGF)16},
      pubmed       = {pmid:38385304},
      pmc          = {pmc:PMC11141665},
      doi          = {10.3324/haematol.2023.284346},
      url          = {https://inrepo02.dkfz.de/record/290602},
}